[HTML][HTML] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie… - PLoS …, 2020 - journals.plos.org
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie… - PLoS …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

[PDF][PDF] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie, B Rous… - PLoS Med, 2020 - core.ac.uk
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

[HTML][HTML] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel… - PLoS …, 2020 - researchportal.ukhsa.gov.uk
Background: The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

[PDF][PDF] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie, B Rous… - 2020 - ore.exeter.ac.uk
BACKGROUND: The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: a population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie, B Rous… - 2020 - repository.cam.ac.uk
Background The serum biomarker Cancer Antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

[PDF][PDF] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel… - PLoS …, 2020 - minerva-access.unimelb.edu.au
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: a population-based cohort study

G Funston, W Hamilton, G Abel… - PL o S …, 2020 - research.manchester.ac.uk
Background The serum biomarker Cancer Antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie, B Rous… - PLoS Medicine, 2020 - go.gale.com
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

[PDF][PDF] The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

G Funston, W Hamilton, G Abel, EJ Crosbie, B Rous… - PLoS …, 2020 - scholar.archive.org
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …